Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

MicroRNAs may help diagnose and treat hair loss disorders.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Androgens increase cervical cancer risk and affect its development.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

MicroRNAs and AI can improve cashmere goat hair quality and aid in hair disorder diagnosis.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

The conclusion suggests that treatments targeting root causes of chronic diseases may be developed by focusing on gene expression and lifestyle factors.

Vitamin D receptor is crucial for hair health and may help treat hair loss.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.